Hanno Erythropel

Dr. Hanno Erythropel

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2020 in Science
Verified
Journal Article
Closed access
JZJulie B. Zimmerman
Julie B. Zimmerman
PAPaul T. Anastas
Paul T. Anastas
HEHanno Erythropel
Hanno Erythropel
WLWalter Leitner
Walter Leitner
The material basis of a sustainable society will depend on chemical products and processes that are designed following principles that make them conducive to life. Important inherent properties of molecules need to be considered from the earliest stage—the design stage—to address whether compounds and processes are depleting versus renewable, toxic versus benign, and persistent versus readily degradable. Products, feedstocks, and manufacturing processes will need to integrate the principles of green chemistry and green engineering under an expanded definition of performance that includes sustainability considerations. This transformation will require the best of the traditions of science and innovation coupled with new emerging systems thinking and systems design that begins at the molecular level and results in a positive impact on the global scale.

3 April 2018 in Green Chemistry
Verified
Journal Article
Closed access
PDF file
HEHanno Erythropel
Hanno Erythropel
JZJulie B. Zimmerman
Julie B. Zimmerman
TWTamara M. de Winter
Tamara M. de Winter
LPLaurène Petitjean
Laurène Petitjean
FMFjodor Melnikov
Fjodor Melnikov
PAPaul T. Anastas
Paul T. Anastas
A broad overview of the achievements and emerging areas in the field of Green Chemistry.

20 August 2002 in Circulation
Verified
Journal Article
Closed access
PDF file
PFPaul Fedak
Paul Fedak
SVSubodh Verma
Subodh Verma
TDTirone E. David
Tirone E. David
RLRichard L. Leask
Richard L. Leask
RWRichard D. Weisel
Richard D. Weisel
JBJagdish Butany
Jagdish Butany
Ou are contacted by a concerned 34-year-old airline pilot with a leaky bicuspid aortic valve recently diagnosed by an echocardiogram that had been requested by his new employer as part of a routine medical assessment. He claims that he is perfectly healthy but is at risk of losing his job over his condition. He is concerned that his disease is hereditary and that his children may also be at risk. The patient, his attorney, and his insurance company have requested a statement from you as to the cause, possible complications, and treatment options associated with a con- genital malformation of the aortic valve. The bicuspid aortic valve (BAV) is the most common congenital cardiac malformation, occurring in 1% to 2% of the population. The majority of BAV patients develop com- plications requiring treatment. Physicians are often chal- lenged when asked to provide evidence-based advice about BAV disease because the pathogenesis and pathophysiology of this disease are not well understood.

7 November 2014 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
HEHanno Erythropel
Hanno Erythropel
Milan MaricMilan Maric
Milan Maric
JNJim Nicell
Jim Nicell
RLRichard L. Leask
Richard L. Leask
VYViviane Yargeau
Viviane Yargeau

1 November 2009 in New Journal of Physics
Verified
Journal Article
Open access
MLM Leduc
M Leduc
DGD Guay
D Guay
RLR L Leask
R L Leask
SCSylvain Coulombe
Sylvain Coulombe

1 March 2009 in Cardiovascular Pathology
Verified
Journal Article
Closed access
NCNusrat Choudhury
Nusrat Choudhury
OBOlivier Bouchot
Olivier Bouchot
LRLeonie Rouleau
Leonie Rouleau
DTDominique Tremblay
Dominique Tremblay
RCRaymond Cartier
Raymond Cartier
RLRichard L. Leask
Richard L. Leask